Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report

Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report

Abstract Background Apixaban is a non-vitamin K antagonist oral anticoagulant (NOACs) recently emerged as an effective alternative to conventional vitamin K antagonists (VKAs) in the treatment of several thromboembolic disorders. However, in case of overdose or in patients requiring emergency surger...

Full description

Bibliographic Details
Main Authors: Vittorio Dalmastri, Andrea Angelini, Vera Minerva, Melissa Ballarini, Francesco Grammatico, Paola Todeschini, Attilia Maria Pizzini, Mauro Silingardi, Gaetano La Manna
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Journal of Medical Case Reports
Subjects:
Apixaban
Hemoadsorption
CytoSorb
Online Access:https://doi.org/10.1186/s13256-023-03949-3

Similar Items

Similar Items